{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:19:18Z","timestamp":1794565158150,"version":"4.9.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672523"],"award-info":[{"award-number":["81672523"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403346"],"award-info":[{"award-number":["82403346"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403330"],"award-info":[{"award-number":["82403330"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hyperglycemia is common in patients with bladder cancer and has been implicated in disease progression, yet the molecular link between a high-glucose milieu and tumor aggressiveness remains poorly defined. Here we identify a noncanonical, nuclear role of hexokinase 2 (HK2) that couples systemic hyperglycemia to MYC-driven glycolysis and stemness in bladder cancer. High glucose promotes nuclear translocation of HK2, where HK2 directly binds the central region of MYC to form a functional transcriptional complex. This HK2\u2013MYC complex occupies the promoters of key glycolytic genes, including HK2 and lactate dehydrogenase A (LDHA), and synergistically activates their transcription, thereby enhancing glycolytic flux and upregulating stemness-associated markers such as CD44. Genetic or pharmacologic inhibition of HK2 attenuates high glucose\u2013induced proliferation, colony formation, and glycolytic reprogramming in vitro. In mouse models, hyperglycemia accelerates tumor growth, whereas treatment with the HK2 inhibitor lonidamine mitigates tumor progression in the hyperglycemic setting. Analysis of human bladder cancer specimens reveals that HK2 expression positively correlates with MYC and LDHA levels and associates with worse patient survival, particularly in patients with hyperglycemia. Collectively, our findings uncover a metabolic\u2013transcriptional coupling pathway in which nuclear HK2 functions as a MYC cofactor to drive glycolysis and stemness under high-glucose conditions, and they suggest that targeting HK2 may represent a rational therapeutic strategy for patients with bladder cancer and coexisting hyperglycemia or diabetes.<\/jats:p>","DOI":"10.1038\/s41419-026-08714-0","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T12:05:06Z","timestamp":1775649906000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Nuclear hexokinase 2 couples hyperglycemia to MYC-driven glycolytic and stemness programs in bladder cancer"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6331-5025","authenticated-orcid":false,"given":"Shuangjie","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0116-5408","authenticated-orcid":false,"given":"Jihang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3717-3380","authenticated-orcid":false,"given":"Haotian","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0479-3151","authenticated-orcid":false,"given":"Yuyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"8714_CR1","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","volume":"20","author":"LMC van Hoogstraten","year":"2023","unstructured":"van Hoogstraten LMC, Vrieling A, van der Heijden AG, Kogevinas M, Richters A, Kiemeney LA. Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice. Nat Rev Clin Oncol. 2023;20:287\u2013304.","journal-title":"Nat Rev Clin Oncol"},{"key":"8714_CR2","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","volume":"5","author":"N Lobo","year":"2022","unstructured":"Lobo N, Afferi L, Moschini M, Mostafid H, Porten S, Psutka SP, et al. Epidemiology, screening, and prevention of bladder cancer. Eur Urol Oncol. 2022;5:628\u201339.","journal-title":"Eur Urol Oncol"},{"key":"8714_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05938-2","volume":"14","author":"K Xiao","year":"2023","unstructured":"Xiao K, Peng S, Lu J, Zhou T, Hong X, Chen S, et al. UBE2S interacting with TRIM21 mediates the K11-linked ubiquitination of LPP to promote the lymphatic metastasis of bladder cancer. Cell Death Dis. 2023;14:408.","journal-title":"Cell Death Dis"},{"key":"8714_CR4","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.7150\/ijbs.98772","volume":"20","author":"J Wu","year":"2024","unstructured":"Wu J, Huang M, Dong W, Chen Y, Zhou Q, Zhang Q, et al. SUMO E3 ligase MUL1 inhibits lymph node metastasis of bladder cancer by mediating mitochondrial HSPA9 translocation. Int J Biol Sci. 2024;20:3986\u20134006.","journal-title":"Int J Biol Sci"},{"key":"8714_CR5","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s12672-025-02218-7","volume":"16","author":"Y He","year":"2025","unstructured":"He Y, Chen Y, Gao C. A Mendelian randomization study on the association between type 2 diabetes and the risk of bladder cancer. Discov Oncol. 2025;16:446.","journal-title":"Discov Oncol"},{"key":"8714_CR6","doi-asserted-by":"crossref","unstructured":"Gill E, Sandhu G, Ward DG, Perks CM, Bryan RT. The sirenic links between diabetes, obesity, and bladder cancer. Int J Mol Sci 2021;22.","DOI":"10.3390\/ijms222011150"},{"key":"8714_CR7","doi-asserted-by":"crossref","unstructured":"Barba I, Carrillo-Bosch L, Seoane J. Targeting the Warburg effect in cancer: Where do we stand? Int J Mol Sci. 2024;25.","DOI":"10.3390\/ijms25063142"},{"key":"8714_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02119-3","volume":"23","author":"M Tufail","year":"2024","unstructured":"Tufail M, Jiang CH, Li N. Altered metabolism in cancer: insights into energy pathways and therapeutic targets. Mol Cancer. 2024;23:203.","journal-title":"Mol Cancer"},{"key":"8714_CR9","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.tem.2024.01.011","volume":"35","author":"Z Yang","year":"2024","unstructured":"Yang Z, Zheng Y, Gao Q. Lysine lactylation in the regulation of tumor biology. Trends Endocrinol Metab. 2024;35:720\u201331.","journal-title":"Trends Endocrinol Metab"},{"key":"8714_CR10","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3892\/ol.2025.15339","volume":"30","author":"Y Qian","year":"2025","unstructured":"Qian Y, Zhu X, Niu D, Tang Q, Jin C. Advancements in research on the role of the key glycolytic enzyme hexokinase 2 in the regulation of tumor immune evasion (Review). Oncol Lett. 2025;30:593.","journal-title":"Oncol Lett"},{"key":"8714_CR11","doi-asserted-by":"publisher","first-page":"790","DOI":"10.7150\/ijms.105553","volume":"22","author":"K He","year":"2025","unstructured":"He K, Tao F, Lu Y, Fang M, Huang H, Zhou Y. The role of HK2 in tumorigenesis and development: potential for targeted therapy with natural products. Int J Med Sci. 2025;22:790\u2013805.","journal-title":"Int J Med Sci"},{"key":"8714_CR12","doi-asserted-by":"crossref","unstructured":"Afonso J, Goncalves C, Costa M, Ferreira D, Santos L, Longatto-Filho A, et al. Glucose metabolism reprogramming in bladder cancer: hexokinase 2 (HK2) as prognostic biomarker and target for bladder cancer therapy. Cancers. 2023;15.","DOI":"10.3390\/cancers15030982"},{"key":"8714_CR13","doi-asserted-by":"crossref","unstructured":"Lee SH, Golinska M, Griffiths JR. HIF-1-independent mechanisms regulating metabolic adaptation in hypoxic cancer cells. Cells. 2021;10.","DOI":"10.3390\/cells10092371"},{"key":"8714_CR14","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.1038\/onc.2017.13","volume":"36","author":"W Wan","year":"2017","unstructured":"Wan W, Peng K, Li M, Qin L, Tong Z, Yan J, et al. Histone demethylase JMJD1A promotes urinary bladder cancer progression by enhancing glycolysis through coactivation of hypoxia inducible factor 1alpha. Oncogene. 2017;36:3868\u201377.","journal-title":"Oncogene"},{"key":"8714_CR15","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1093\/jmcb\/mjaa040","volume":"12","author":"C Zhang","year":"2020","unstructured":"Zhang C, Liu J, Xu D, Zhang T, Hu W, Feng Z. Gain-of-function mutant p53 in cancer progression and therapy. J Mol Cell Biol. 2020;12:674\u201387.","journal-title":"J Mol Cell Biol"},{"key":"8714_CR16","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1111\/jcmm.17322","volume":"26","author":"Q Yu","year":"2022","unstructured":"Yu Q, Dai W, Ji J, Wu L, Feng J, Li J, et al. Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the c-myc\/hexokinase 2 pathway. J Cell Mol Med. 2022;26:3031\u201345.","journal-title":"J Cell Mol Med"},{"key":"8714_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cmet.2020.12.015","volume":"33","author":"D Xu","year":"2021","unstructured":"Xu D, Shao F, Bian X, Meng Y, Liang T, Lu Z. The Evolving Landscape of Noncanonical Functions of Metabolic Enzymes in Cancer and Other Pathologies. Cell Metab. 2021;33:33\u201350.","journal-title":"Cell Metab"},{"key":"8714_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0065-6","volume":"50","author":"MT Snaebjornsson","year":"2018","unstructured":"Snaebjornsson MT, Schulze A. Non-canonical functions of enzymes facilitate cross-talk between cell metabolic and regulatory pathways. Exp Mol Med. 2018;50:1\u201316.","journal-title":"Exp Mol Med"},{"key":"8714_CR19","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.cmet.2022.08.002","volume":"34","author":"D Guo","year":"2022","unstructured":"Guo D, Tong Y, Jiang X, Meng Y, Jiang H, Du L, et al. Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IkappaBalpha. Cell Metab. 2022;34:1312\u201324.e1316.","journal-title":"Cell Metab"},{"key":"8714_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2024.101435","volume":"12","author":"Y Duan","year":"2025","unstructured":"Duan Y, Liu Z, Wang Q, Zhang J, Liu J, Zhang Z, et al. Targeting MYC: Multidimensional regulation and therapeutic strategies in oncology. Genes Dis. 2025;12:101435.","journal-title":"Genes Dis"},{"key":"8714_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06446-7","volume":"15","author":"M Li","year":"2024","unstructured":"Li M, Yu J, Ju L, Wang Y, Jin W, Zhang R, et al. USP43 stabilizes c-Myc to promote glycolysis and metastasis in bladder cancer. Cell Death Dis. 2024;15:44.","journal-title":"Cell Death Dis"},{"key":"8714_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119694","volume":"280","author":"AS Chhipa","year":"2021","unstructured":"Chhipa AS, Patel S. Targeting pyruvate kinase muscle isoform 2 (PKM2) in cancer: What do we know so far? Life Sci. 2021;280:119694.","journal-title":"Life Sci"},{"key":"8714_CR23","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/nature08697","volume":"463","author":"CJ David","year":"2010","unstructured":"David CJ, Chen M, Assanah M, Canoll P, Manley JL. HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature. 2010;463:364\u20138.","journal-title":"Nature"},{"key":"8714_CR24","doi-asserted-by":"crossref","unstructured":"Li Y, Zhang S, Li Y, Liu J, Li Q, Zang W, et al. The regulatory network of hnRNPs underlying regulating PKM alternative splicing in tumor progression. Biomolecules 2024,14.","DOI":"10.3390\/biom14050566"},{"key":"8714_CR25","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1158\/0008-5472.CAN-18-2847","volume":"79","author":"B Das","year":"2019","unstructured":"Das B, Pal B, Bhuyan R, Li H, Sarma A, Gayan S, et al. MYC regulates the HIF2alpha stemness pathway via Nanog and Sox2 to maintain self-renewal in cancer stem cells versus non-stem cancer cells. Cancer Res. 2019;79:4015\u201325.","journal-title":"Cancer Res"},{"key":"8714_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13046-024-03021-y","volume":"43","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Zhang Y. Transcriptional regulation of cancer stem cell: regulatory factors elucidation and cancer treatment strategies. J Exp Clin Cancer Res. 2024;43:99.","journal-title":"J Exp Clin Cancer Res"},{"key":"8714_CR27","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41580-018-0029-7","volume":"19","author":"X Li","year":"2018","unstructured":"Li X, Egervari G, Wang Y, Berger SL, Lu Z. Regulation of chromatin and gene expression by metabolic enzymes and metabolites. Nat Rev Mol Cell Biol. 2018;19:563\u201378.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8714_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02009-8","volume":"23","author":"J Zhang","year":"2024","unstructured":"Zhang J, Ouyang F, Gao A, Zeng T, Li M, Li H, et al. ESM1 enhances fatty acid synthesis and vascular mimicry in ovarian cancer by utilizing the PKM2-dependent Warburg effect within the hypoxic tumor microenvironment. Mol Cancer. 2024;23:94.","journal-title":"Mol Cancer"},{"key":"8714_CR29","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1242\/jcs.174870","volume":"128","author":"W Yang","year":"2015","unstructured":"Yang W, Lu Z. Pyruvate kinase M2 at a glance. J Cell Sci. 2015;128:1655\u201360.","journal-title":"J Cell Sci"},{"key":"8714_CR30","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1073\/pnas.1217203110","volume":"110","author":"Q Sun","year":"2013","unstructured":"Sun Q, Carrasco YP, Hu Y, Guo X, Mirzaei H, Macmillan J, et al. Nuclear export inhibition through covalent conjugation and hydrolysis of Leptomycin B by CRM1. Proc Natl Acad Sci USA. 2013;110:1303\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8714_CR31","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/s41556-022-00925-9","volume":"24","author":"GE Thomas","year":"2022","unstructured":"Thomas GE, Egan G, Garcia-Prat L, Botham A, Voisin V, Patel PS, et al. The metabolic enzyme hexokinase 2 localizes to the nucleus in AML and normal haematopoietic stem and progenitor cells to maintain stemness. Nat Cell Biol. 2022;24:872\u201384.","journal-title":"Nat Cell Biol"},{"key":"8714_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63377-3","volume":"16","author":"H Zhan","year":"2025","unstructured":"Zhan H, Wang H, Pan B, Lu J, Xiao K, Lai J, et al. Reprogramming the tumor microenvironment with c-MYC-based gene circuit platform to enhance specific cancer immunotherapy. Nat Commun. 2025;16:7983.","journal-title":"Nat Commun"},{"key":"8714_CR33","doi-asserted-by":"publisher","DOI":"10.34133\/research.0735","volume":"8","author":"C Zhang","year":"2025","unstructured":"Zhang C, Liu S, Zhang J, Lu J, Chen Z, Pan B, et al. A multifunctional Fe-EGCG@RSL3 nanomedicine synergizes ferroptosis induction and tumor microenvironment remodeling for enhanced bladder cancer immunotherapy. Research. 2025;8:0735.","journal-title":"Research"},{"key":"8714_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202501565","volume":"37","author":"H Wang","year":"2025","unstructured":"Wang H, Zhan H, Pan B, Zeng L, Chen Z, Liu S, et al. Engineering CRISPR system-based bacterial outer membrane vesicle potentiates T cell immunity for enhanced cancer immunotherapy. Adv Mater. 2025;37:e2501565.","journal-title":"Adv Mater"},{"key":"8714_CR35","first-page":"151","volume":"1866","author":"K Nath","year":"2016","unstructured":"Nath K, Guo L, Nancolas B, Nelson DS, Shestov AA, Lee SC, et al. Mechanism of antineoplastic activity of lonidamine. Biochim Biophys Acta. 2016;1866:151\u201362.","journal-title":"Biochim Biophys Acta"},{"key":"8714_CR36","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1007\/s10238-023-01051-y","volume":"23","author":"H Zhu","year":"2023","unstructured":"Zhu H, Jia Z, Li YR, Danelisen I. Molecular mechanisms of action of metformin: latest advances and therapeutic implications. Clin Exp Med. 2023;23:2941\u201351.","journal-title":"Clin Exp Med"},{"key":"8714_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155426","volume":"126","author":"S Liu","year":"2024","unstructured":"Liu S, Wang X, Sun X, Wei B, Jiang Z, Ouyang Y, et al. Oridonin inhibits bladder cancer survival and immune escape by covalently targeting HK1. Phytomedicine. 2024;126:155426.","journal-title":"Phytomedicine"},{"key":"8714_CR38","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1016\/j.molcel.2021.04.002","volume":"81","author":"Y Tong","year":"2021","unstructured":"Tong Y, Guo D, Lin SH, Liang J, Yang D, Ma C, et al. SUCLA2-coupled regulation of GLS succinylation and activity counteracts oxidative stress in tumor cells. Mol Cell. 2021;81:2303\u201316.e2308.","journal-title":"Mol Cell"},{"key":"8714_CR39","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1016\/j.molcel.2021.05.005","volume":"81","author":"R Liu","year":"2021","unstructured":"Liu R, Lee JH, Li J, Yu R, Tan L, Xia Y, et al. Choline kinase alpha 2 acts as a protein kinase to promote lipolysis of lipid droplets. Mol Cell. 2021;81:2722\u201335.e2729.","journal-title":"Mol Cell"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08714-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08714-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08714-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:30:15Z","timestamp":1779208215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08714-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8714"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08714-0","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]},"assertion":[{"value":"29 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Committee for Ethical Review of Research Involving Human Subjects of the First Hospital of China Medical University (Approval No. [2022]102), and written informed consent was obtained from all patients. All methods involving human participants were performed in accordance with the relevant guidelines and regulations. All animals were cared for and treated in accordance with institutional guidelines and the protocol approved by the Animal Care and Use Committee of China Medical University (IACUC Issue No. KT2022608), and all methods involving animals were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"493"}}